USD92.58 ₽ EUR100.28 ₽ telegram Telegram
2024-02-29 обновлены отчеты компании TGTX: 202320222021
TG Therapeutics logo
TG Therapeutics TGTX
$ 16.19 -1.4%

TG Therapeutics Мультипликаторы 2011-2024 | TGTX

Мультипликаторы по годам TG Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

191.2 -10.3 -4.4 -19.9 -7.3 -1.9 -6.1 -2.9 -5.9 -8.7 -7.6 -2.6 -2.3

P/S

10.4 734.7 228.7 36626.0 8284.6 2149.8 4765.8 1512.6 2447.4 3183.7 1024.0 2512.9 -

EPS

0.1 -1.5 -2.6 -2.4 -2.0 -2.3 -1.9 -1.6 -1.4 -1.6 -0.8 -1.4 -0.4

EV (Enterprise Value)

2.5 млрд 2.08 млрд 1.37 млрд 5.12 млрд 1.27 млрд 344 млн 700 млн 224 млн 330 млн 436 млн 124 млн 37.9 млн -1.53 млн

EBITDA per Share

0.15 -1.42 -2.61 -2.37 -1.91 -2.31 -1.91 -1.61 -1.38 -1.64 -0.794 -1.97 -0.458

EV/EBITDA

-3.8 -18.5 -7.0 -1.6 -5.6 -2.6 -5.0 -7.7 -5.8 -1.3 3.3

PEG

-6.87 6.58 -0.39 -1.59 -0.49 0.09 0.32 0.18 -0.37 0.08 -0.18 0.01 0.03

P/B

15.1 34.9 6.5 10.7 32.6 13.6 10.8 6.4 3.7 6.1 3.9 3.1 0.2

P/CF

-77.1 -11.6 -5.2 -26.0 -9.5 -2.5 -7.7 -3.7 -8.3 -13.8 -14.4 -9.2 -22.5

ROE %

7.90 -338.53 -146.78 -53.79 -447.68 -721.76 -176.85 -218.17 -61.97 -69.64 -51.13 -116.22 -8.86

ROA %

3.84 -102.46 -91.70 -44.66 -106.05 -207.47 -121.66 -142.85 -55.47 -64.30 -42.56 -81.87 -5.36

ROCE %

12.86 -329.15 -145.38 -52.68 -215.18 -389.62 -170.99 -208.34 -61.37 -68.26 -48.26 -129.87 -6.22

Current Ratio

1.9 1.4 2.7 5.9 1.8 2.0 3.3 3.0 8.3 16.6 6.7 8.3 6.1

DSO

- - 37.9 - - 228.1 259.8 200.9 445.6 204.8 65.1 - -

DIO

514.3 - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Операционный цикл

514.3 - 37.9 - - - - - - - - - -

Финансовый цикл

514.3 - 37.9 - - - - - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально TG Therapeutics

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.8 -0.34 -0.28 - -0.26 -0.3 -0.51 - -0.65 -0.59 -0.69 - -0.73 -0.47 -0.48 -0.44 -0.69 -0.42 -0.43 -0.68 -0.43 -0.59 -0.59 -0.46 -0.48 -0.45 -0.52 -0.48 -0.5 -0.33 -0.28 -0.37 -0.28 -0.38 -0.35 -0.48 -0.51 -0.36 -0.25 - -0.16 -0.29 -0.17 - -0.16 -0.16 -2.03 - -0.01 -0.15 -

EBITDA per Share

- - -0.26 - -0.26 -0.29 -0.5 - -0.64 -0.59 -0.68 - -0.72 -0.45 -0.48 - -0.68 -0.41 -0.43 - -0.44 0.6 -0.59 - -0.48 -0.45 -0.52 - -0.51 -0.33 -0.29 - -0.29 -0.38 -0.36 - -0.51 -0.36 -0.25 - -0.17 -0.29 -0.17 - -0.17 -0.26 -3.43 - -0.01 -0.16 -

ROE %

-227.20 -332.00 -245.70 -107.55 -135.04 -126.88 -115.97 -68.33 -85.11 -74.41 -64.10 -36.81 -139.28 -282.88 -366.48 -447.68 -569.28 -550.15 -640.02 -721.76 -543.74 -449.57 -308.24 -176.85 -196.79 -218.94 -220.95 -218.17 -169.51 -113.72 -86.23 -61.97 -68.10 -76.44 -74.57 -69.64 -57.55 -47.14 -48.61 -36.99 -63.26 -78.16 -78.92 -130.85 -131.14 -105.17 -90.90 - -0.30 -2.93 -

ROA %

-23.46 -74.31 -68.85 -55.31 -76.21 -80.68 -80.89 -53.73 -67.66 -60.69 -52.83 -30.55 -54.83 -78.89 -92.65 -106.05 -146.19 -148.80 -179.37 -207.47 -174.75 -166.53 -142.86 -121.66 -133.19 -146.13 -146.04 -142.85 -115.15 -81.86 -67.91 -55.47 -61.62 -69.70 -68.45 -64.30 -52.11 -41.46 -41.33 -30.79 -41.95 -43.63 -38.53 -66.20 -66.38 -55.41 -48.60 - -0.18 -1.77 -

ROCE %

-210.41 -314.87 -234.61 -104.22 -131.55 -124.08 -114.13 -67.59 -84.09 -73.27 -62.83 -35.97 -193.58 -334.68 -416.94 -339.49 -482.31 -467.52 -190.98 -131.30 -178.45 -82.78 -309.70 -130.87 -200.37 -222.71 -224.96 -153.18 -166.79 -110.91 -83.08 -44.83 -66.61 -74.77 -72.84 -46.19 -57.79 -47.63 -49.25 -37.42 -66.39 -83.75 -95.38 -205.26 -205.57 -176.92 -151.82 - -0.31 -3.09 -

Current Ratio

2.0 1.2 1.2 1.4 1.9 2.0 2.3 2.7 4.2 4.9 5.3 5.9 5.9 5.9 5.9 1.3 1.3 1.3 1.3 1.4 1.4 1.4 1.4 3.2 3.2 3.2 3.2 2.9 2.9 2.9 2.9 9.5 9.5 9.5 9.5 13.1 13.1 13.1 13.1 6.0 6.0 6.0 6.0 3.4 3.4 3.4 3.4 3.0 2.5 2.5 2.5

DSO

15.6 74.1 50.4 - 42.7 76.1 51.9 - 52.0 50.3 44.4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

829.4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

845.0 74.1 50.4 - 42.7 76.1 51.9 - 52.0 50.3 44.4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Финансовый цикл

845.0 74.1 50.4 - 42.7 76.1 51.9 - 52.0 50.3 44.4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Все данные представлены в валюте USD